The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

Although there is no specific regulation of marketing to children in South Africa, the Consumer Protection Act 58 of 2008 has ...

Weight-loss injections known as GLP-1 receptor agonists could nearly halve the risk of obesity-related cancers, according to ...

As National Women’s Health Week approaches, new global data highlighting projected rises in breast and ovarian cancer through ...

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.

Restricting the eating window to 8 hours at any time of day for 3 months can result in significant weight loss for at least a ...

The new site will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines.

Excess weight linked to higher risk of depression, memory issues, and vertigo in long COVID * Obesity significantly increases ...

As more doctors and patients turn to the latest weight-loss drugs, researchers are trying to figure out which drug is right ...

CM Rekha Gupta praised the contribution of mothers and doctors on the occasion of Mother’s Day, calling them the two ...